HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sub-New Stocks

496.267

-8.246-1.63%

Number of Gainers:22

Number of Losers:25

Number of Flat:14

PE:- -

High:506.281

Open:504.573

Low:490.208

Close:504.513

Loading ...

Megain Holding (Cayman) Co. Ltd. Conducted Annual General Meeting

Zylox-Tonbridge Files Next Day Disclosure to HKEX Announcing Repurchase of 270,000 Shares at HKD 556,450

Chaoju Eye Care Holdings Ltd. Conducted Annual General Meeting

Kindstar Globalgene Technology Inc. Conducted Annual General Meeting

BRIEF-JPMorgan Chase & Co's Long Position In Bilibili Increases To 11.68% On May 30 - HKEX

BRIEF-Blackrock's Long Position In Bilibili Decreases To 5.56% On May 30 - HKEX

Central China Management Co. Ltd. Announces Continued Trading Suspension on Hong Kong Stock Exchange

JPMorgan Chase & Co's Long Position in Bilibili Inc Increases to 11.68% on May 30 From 10.15% - HKEX

THOMSON REUTERS

XPeng Strikes Partnership With Huawei

MT Newswires Live

HUTCHMED and Innovent Announce Regulatory Review Acceptance in China for Fruquintinib and Sintilimab Combination in Advanced Renal Cell Carcinoma Treatment

BRIEF-HUTCHMED (China) Says NDA Acceptance In China For Fruquintinib Combination With Sintilimab

HUTCHMED (China) Ltd - Nda Acceptance in China for Fruquintinib Combination With Sintilimab

THOMSON REUTERS

Zhaoke Ophthalmology Ltd. Secures FDA Clearance for IND Application of CsA Ophthalmic Gel for Dry Eye Disease Treatment

Zhaoke Ophthalmology Ltd - FDA Clearance of Ind Application for Csa Ophthalmic Gel

THOMSON REUTERS

Acotec Scientific Holdings Ltd. Receives PRC National Medical Products Administration Approval for AcoArt Verbena® Paclitaxel-Coated Balloon Catheter

Acotec Scientific - Approval for Vertebral Artery Paclitaxel-Coated- Balloon Dilatation Catheter Acoart Verbena by Nmpa

THOMSON REUTERS

Market Chatter: Investor Thirst for Chinese Fresh Drink Makers Saturates Following Slew of Share Offerings

MT Newswires Live

U.S.-Listed Shares of Li Auto up 6.3%, Tracking Rebound in Domestic Stock

THOMSON REUTERS

Brii Biosciences Ltd. Conducted Annual General Meeting

China, HK shares rise as banks and carmakers rally; trade talks in focus

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK1587/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1587","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1587\",,,,,undefined,":{"symbol":"BK1587","market":"HK","secType":"PLATE","nameCN":"Sub-New Stocks","latestPrice":496.26675,"timestamp":1749197315322,"preClose":504.51276,"halted":0,"volume":210057383,"delay":0,"changeRate":-0.016344,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-8.246002,"latestTime":"06-06 16:00:00","open":504.5734,"high":506.28125,"low":490.208,"amount":11720490169,"amplitude":0.031859,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1749432600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1749173400000,1749182400000],[1749186000000,1749196800000]],"pbRate":2.560033,"peRate":38.285001,"turnoverRate":0.003941,"increases":19,"decrements":26,"flats":14,"marketCap":1190751644540,"floatMarketCap":1046162677404},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1587\",,,,,undefined,":{"symbol":"BK1587","high":506.28125,"amplitude":0.031859,"preClose":504.51276,"low":490.208,"pbRate":"2.560033","latestPrice":496.26675,"volume":210057383,"delay":0,"open":504.5734,"prevYearClose":452.04388,"prevWeekClose":497.461,"prevMonthClose":497.461,"prevQuarterClose":481.893,"fiveDayClose":497.461,"twentyDayClose":474.003,"sixtyDayClose":523.09,"secType":"PLATE","market":"HK","turnoverRate":0.003941,"peRate":38.285001,"marketCap":1190751644540,"floatMarketCap":1046162677404,"timestamp":1749197315322,"nameCN":"Sub-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1587\",,,,undefined,":{"bkCode":"BK1587","up":22,"down":25,"flat":14},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1587\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541852279","title":"Megain Holding (Cayman) Co. Ltd. Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2541852279","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541852279?lang=en_us&edition=fundamental","pubTime":"2025-06-06 20:04","pubTimestamp":1749211495,"startTime":"0","endTime":"0","summary":"Megain Holding  Co. Ltd. held its annual general meeting on 6 June 2025. All proposals presented at the meeting were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Megain Holding  Co. Ltd. published the original content used to generate this news brief on June 06, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250606:nNDL7WPJYL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1163","BK1587","06939"],"gpt_icon":0},{"id":"2541851315","title":"Zylox-Tonbridge Files Next Day Disclosure to HKEX Announcing Repurchase of 270,000 Shares at HKD 556,450","url":"https://stock-news.laohu8.com/highlight/detail?id=2541851315","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541851315?lang=en_us&edition=fundamental","pubTime":"2025-06-06 18:50","pubTimestamp":1749207011,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge Medical Technology Co., Ltd. has filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, reporting the repurchase of 270,000 shares at an aggregate price of HKD 556,450. Out of these, 30,000 shares are held as treasury shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zylox-Tonbridge Medical Technology Co .Ltd. published the original content used to generate this news brief on June 06, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250606:nNDL9DbHS6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","02190","BK1574","BK1583","BK1100"],"gpt_icon":0},{"id":"2541654858","title":"Chaoju Eye Care Holdings Ltd. Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2541654858","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541654858?lang=en_us&edition=fundamental","pubTime":"2025-06-06 17:31","pubTimestamp":1749202312,"startTime":"0","endTime":"0","summary":"Chaoju Eye Care Holdings Ltd. held its Annual General Meeting on June 6, 2025. All proposed ordinary resolutions were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chaoju Eye Care Holdings Ltd. published the original content used to generate this news brief on June 06, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250606:nNDL1wzhn3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","02219","BK1209"],"gpt_icon":0},{"id":"2541907996","title":"Kindstar Globalgene Technology Inc. Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2541907996","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541907996?lang=en_us&edition=fundamental","pubTime":"2025-06-05 22:36","pubTimestamp":1749134194,"startTime":"0","endTime":"0","summary":"Kindstar Globalgene Technology Inc. held its annual general meeting on June 5, 2025. The proposal to receive the audited consolidated financial statements and the reports of the directors and auditors for the year ended December 31, 2024, was approved. The proposal to re-elect Dr. Huang Shiang as an executive Director of the Company was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kindstar Globalgene Technology Inc. published the original content used to generate this news brief on June 05, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDL47hNJd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09960","BK1219","BK1587"],"gpt_icon":0},{"id":"2541202103","title":"BRIEF-JPMorgan Chase & Co's Long Position In Bilibili Increases To 11.68% On May 30 - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2541202103","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541202103?lang=en_us&edition=fundamental","pubTime":"2025-06-05 18:32","pubTimestamp":1749119569,"startTime":"0","endTime":"0","summary":"BRIEF-JPMorgan Chase & Co's Long Position In Bilibili Increases To 11.68% On May 30 - HKEXJune 5 (Reuters) - JPMORGAN CHASE & CO'S LONG POSITION IN BILIBILI INCREASES TO 11.68% ON MAY 30 FROM 10.15% - HKEXFurther company coverage: 9626.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"94feda8dff1acbfa36f1d28f276c473d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nFWN3S70WQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001069.SGD","SG9999001093.SGD","IE0034224299.USD","LU2097828714.EUR","SG9999006597.SGD","BK1608","BK1618","BK1095","BK1588","BK1104","09626","LU2097828631.EUR","LU2097828474.EUR","LU2097828557.USD","LU2097828805.USD","SG9999001051.SGD","BK1615","BK1587","BK1575","SG9999003461.SGD"],"gpt_icon":0},{"id":"2541021080","title":"BRIEF-Blackrock's Long Position In Bilibili Decreases To 5.56% On May 30 - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2541021080","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541021080?lang=en_us&edition=fundamental","pubTime":"2025-06-05 18:32","pubTimestamp":1749119540,"startTime":"0","endTime":"0","summary":"BRIEF-Blackrock's Long Position In Bilibili Decreases To 5.56% On May 30 - HKEXJune 5 (Reuters) - Bilibili Inc 9626.HK:BLACKROCK'S LONG POSITION IN BILIBILI DECREASES TO 5.56% ON MAY 30 FROM 6.18% - HKEXFurther company coverage: 9626.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nFWN3S70WS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828474.EUR","SG9999006597.SGD","BK1618","BK1608","SG9999003461.SGD","LU2097828805.USD","SG9999001093.SGD","LU2097828631.EUR","LU2097828714.EUR","BK1615","BK1588","09626","BK1575","BK1095","SG9999001051.SGD","SG9999001069.SGD","LU2097828557.USD","BK1104","IE0034224299.USD","BK1587"],"gpt_icon":0},{"id":"2541902974","title":"Central China Management Co. Ltd. Announces Continued Trading Suspension on Hong Kong Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2541902974","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541902974?lang=en_us&edition=fundamental","pubTime":"2025-06-05 18:04","pubTimestamp":1749117895,"startTime":"0","endTime":"0","summary":"Central China Management Company Limited has announced a continued suspension of trading in its shares on the Hong Kong Stock Exchange, effective since April 2, 2024. The suspension was implemented in accordance with Rule 13.09 of the Listing Rules and the Inside Information Provisions under the Securities and Futures Ordinance in Hong Kong. The company is required to address substantive issues and comply fully with the Listing Rules before trading can resume. Shareholders and investors are advised to exercise caution and consult independent professional advisors if needed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Central China Management Co. Ltd. published the original content used to generate this news brief on June 05, 2025, a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDL70ms5J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1240","09982"],"gpt_icon":0},{"id":"2541026487","title":"JPMorgan Chase & Co's Long Position in Bilibili Inc  Increases to 11.68% on May 30 From 10.15% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2541026487","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541026487?lang=en_us&edition=fundamental","pubTime":"2025-06-05 17:47","pubTimestamp":1749116856,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"94feda8dff1acbfa36f1d28f276c473d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nFWN3S70WQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0034224299.USD","BK1615","LU2097828631.EUR","SG9999001069.SGD","BK1095","SG9999001051.SGD","BK1588","SG9999001093.SGD","SG9999006597.SGD","BK1587","LU2097828805.USD","BK1575","LU2097828557.USD","LU2097828474.EUR","SG9999003461.SGD","BK1618","BK1104","LU2097828714.EUR","09626","BK1608"],"gpt_icon":0},{"id":"2541801091","title":"XPeng Strikes Partnership With Huawei","url":"https://stock-news.laohu8.com/highlight/detail?id=2541801091","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541801091?lang=en_us&edition=fundamental","pubTime":"2025-06-05 12:52","pubTimestamp":1749099164,"startTime":"0","endTime":"0","summary":"XPeng  will partner with Huawei's Intelligent Automotive Solution unit, with the details set to be announced on Thursday, according to a promotional poster.A pre-launch posted showed both XPeng and Huawei will co-develop an augmented reality head-up display or AR-HUD system, China Securities Journal reported Wednesday.The development comes after XPeng Chairman and Chief Executive Officer He Xiaopeng visited Huawei founder Ren Zhengfei, The Standard reported separately the same day.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1119","BK1587","BK1539","09868","BK1575","BK1610","LU0593848301.USD","BK1588"],"gpt_icon":1},{"id":"2541909742","title":"HUTCHMED and Innovent Announce Regulatory Review Acceptance in China for Fruquintinib and Sintilimab Combination in Advanced Renal Cell Carcinoma Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2541909742","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541909742?lang=en_us&edition=fundamental","pubTime":"2025-06-05 07:50","pubTimestamp":1749081005,"startTime":"0","endTime":"0","summary":"HUTCHMED and Innovent Announce Regulatory Review Acceptance in China for Fruquintinib and Sintilimab Combination in Advanced Renal Cell Carcinoma Treatment. HUTCHMED  Limited and Innovent Biologics, Inc. have jointly announced the acceptance of their New Drug Application  by the China National Medical Products Administration . The application is for the combination of fruquintinib and sintilimab for the treatment of patients with advanced renal cell carcinoma who have not responded to prior treatment with a tyrosine kinase inhibitor. This NDA is backed by data from the FRUSICA-2 study, which demonstrated the efficacy and safety of the drug combination compared to monotherapy options. The announcement underscores both companies' commitment to advancing cancer therapies and enhancing treatment options for patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL8P2WdD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1147","BK1191","01911","BK1587","00013","BK1588"],"gpt_icon":0},{"id":"2541097438","title":"BRIEF-HUTCHMED (China) Says NDA Acceptance In China For Fruquintinib Combination With Sintilimab","url":"https://stock-news.laohu8.com/highlight/detail?id=2541097438","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541097438?lang=en_us&edition=fundamental","pubTime":"2025-06-05 07:47","pubTimestamp":1749080867,"startTime":"0","endTime":"0","summary":"BRIEF-HUTCHMED (China) Says NDA Acceptance In China For Fruquintinib Combination With SintilimabJune 5 (Reuters) - HUTCHMED (China) Ltd 0013.HK:NDA ACCEPTANCE IN CHINA FOR FRUQUINTINIB COMBINATION WIT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nFWN3S70VN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","00013","LU1969619763.USD","BK1583","01801","LU2488822045.USD","BK1191","LU2328871848.SGD","BK1588","BK1589","BK1587"],"gpt_icon":0},{"id":"2541979750","title":"HUTCHMED (China) Ltd - Nda Acceptance in China for Fruquintinib Combination With Sintilimab","url":"https://stock-news.laohu8.com/highlight/detail?id=2541979750","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541979750?lang=en_us&edition=fundamental","pubTime":"2025-06-05 07:45","pubTimestamp":1749080738,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nFWN3S70VN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1588","00013","BK1587"],"gpt_icon":0},{"id":"2540705409","title":"Zhaoke Ophthalmology Ltd. Secures FDA Clearance for IND Application of CsA Ophthalmic Gel for Dry Eye Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2540705409","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540705409?lang=en_us&edition=fundamental","pubTime":"2025-06-04 18:08","pubTimestamp":1749031684,"startTime":"0","endTime":"0","summary":"Zhaoke Ophthalmology Ltd. has announced that the U.S. Food and Drug Administration  has cleared its Investigational New Drug  application for its core product, Cyclosporine  Ophthalmic Gel. This gel is being developed for the treatment of moderate-to-severe dry eye disease and will advance to a Phase III, multicenter, randomized, double-masked, active-controlled study. The FDA's clearance allows Zhaoke to incorporate data from its completed pivotal Phase III clinical trial  and ongoing Phase III trial in China into its U.S. development plan. This regulatory milestone marks a significant step forward for Zhaoke in potentially improving patient compliance and quality of life with its innovative once-daily application gel.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financia","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL9fqH1V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","06622","BK1587","BK1191","BK1574"],"gpt_icon":0},{"id":"2540405408","title":"Zhaoke Ophthalmology Ltd - FDA Clearance of Ind Application for Csa Ophthalmic Gel","url":"https://stock-news.laohu8.com/highlight/detail?id=2540405408","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540405408?lang=en_us&edition=fundamental","pubTime":"2025-06-04 18:06","pubTimestamp":1749031586,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nFWN3S70EH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1191","BK1587","06622","BK1574"],"gpt_icon":0},{"id":"2540058386","title":"Acotec Scientific Holdings Ltd. Receives PRC National Medical Products Administration Approval for AcoArt Verbena® Paclitaxel-Coated Balloon Catheter","url":"https://stock-news.laohu8.com/highlight/detail?id=2540058386","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540058386?lang=en_us&edition=fundamental","pubTime":"2025-06-04 16:44","pubTimestamp":1749026695,"startTime":"0","endTime":"0","summary":"Acotec Scientific Holdings Ltd. Receives PRC National Medical Products Administration Approval for AcoArt Verbena Paclitaxel-Coated Balloon Catheter. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acotec Scientific Holdings Ltd. published the original content used to generate this news brief on June 04, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL4NlyGT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1291159041.SGD","LU1023059063.AUD","LU1989764748.USD","LU2265009873.SGD","LU1057294990.SGD","BK4082","LU2506952097.USD","LU0114720955.EUR","LU1791710400.SGD","BK1587","LU2324357040.USD","LU2087625088.SGD","IE0002141913.USD","BK4581","LU0353189680.USD","LU1153585028.USD","LU1983299246.USD","LU1989772923.USD","LU2362541513.USD","LU0077335932.USD","LU2491050154.USD","BK4585","LU1989772840.SGD","LU2242649171.HKD","IE00B2B36J28.USD","LU0823417737.USD","LU0238689110.USD","LU0048584097.USD","BSX","LU2362540622.SGD","LU0882574055.USD","LU1791710582.SGD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0251132253.USD","06669","LU2244417387.USD","BK1100","LU2506952170.USD","LU1804176565.USD","LU2491050071.SGD","LU1366192091.USD","LU0122379950.USD","LU2112291526.USD","LU2506951958.HKD","LU0345769631.USD","LU2362541273.HKD","BK1574","LU1989771016.USD","LU0225283273.USD"],"gpt_icon":0},{"id":"2540030773","title":"Acotec Scientific - Approval for Vertebral Artery Paclitaxel-Coated- Balloon Dilatation Catheter Acoart Verbena by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2540030773","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540030773?lang=en_us&edition=fundamental","pubTime":"2025-06-04 16:40","pubTimestamp":1749026441,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nFWN3S706F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","06669","BK1100","BK1587"],"gpt_icon":0},{"id":"2540030845","title":"Market Chatter: Investor Thirst for Chinese Fresh Drink Makers Saturates Following Slew of Share Offerings","url":"https://stock-news.laohu8.com/highlight/detail?id=2540030845","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540030845?lang=en_us&edition=fundamental","pubTime":"2025-06-04 16:25","pubTimestamp":1749025524,"startTime":"0","endTime":"0","summary":"Investor appetite for Chinese fresh drink companies has been saturated following an increase in share offerings, the South China Morning Post reported Tuesday, citing a report by S&P Global Ratings.The demand for Chinese fresh drinks, which is surging as \"growing as fast as marketing, innovation and supply chains strengthen for this segment,\" could trigger competitive spending and strains, the report said, citing credit analyst Sandy Lim.The mainland Chinese market for fresh drinks is seen to grow by nearly 18% yearly between 2023 and 2028 and could reach 1 trillion yuan in sales by 2027, the report said, citing S&P.Among the mainland drink companies that have offered shares include Mixue , Guming Holdings' , and Auntea Jenny  in Hong Kong, and Chagee in the US, the report said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HSI","BK1587","MHImain","BK1233","513600","02833","MCHmain","LU0211977185.USD","BK1616","01364","02589","LU2488822045.USD","HHImain","02097"],"gpt_icon":1},{"id":"2540650772","title":"U.S.-Listed Shares of Li Auto up 6.3%, Tracking Rebound in Domestic Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2540650772","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540650772?lang=en_us&edition=fundamental","pubTime":"2025-06-03 21:33","pubTimestamp":1748957617,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nL3N3S611V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1587","LU1794554557.SGD","BK1588","BK1539","02015","LU1720050803.USD","BK1119","BK1575"],"gpt_icon":0},{"id":"2540969779","title":"Brii Biosciences Ltd. Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2540969779","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540969779?lang=en_us&edition=fundamental","pubTime":"2025-06-03 20:00","pubTimestamp":1748952047,"startTime":"0","endTime":"0","summary":"Brii Biosciences Ltd. held its annual general meeting on June 3, 2025. During the meeting, several proposals were voted on. The proposal to adopt the audited consolidated financial statements for the year ended December 31, 2024, was approved. The re-election of Dr. Ankang Li as an executive Director was also approved. Additionally, Mr. Gregg Huber Alton and Mr. Yiu Wa Alec Tsui were re-elected as independent non-executive Directors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Brii Biosciences Ltd. published the original content used to generate this news brief on June 03, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL5qVDBJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","BK1587","02137"],"gpt_icon":0},{"id":"2540725206","title":"China, HK shares rise as banks and carmakers rally; trade talks in focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2540725206","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540725206?lang=en_us&edition=fundamental","pubTime":"2025-06-03 16:23","pubTimestamp":1748939007,"startTime":"0","endTime":"0","summary":"China, HK shares rise as banks and carmakers rally; trade talks in focusUpdates with closing prices","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"b3218741544ebb5eaf105d9966c647f4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nL2N3S6079:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1575","BK1587","BK1119","LU1720050803.USD","BK1539","BK1588","LU1794554557.SGD"],"gpt_icon":1}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":80,"code":"91000000","status":"200"}]}}